Arulvathani Arudchandran
FDA investigator
Appears on 1 document from 2020, mostly at sites in New Hampshire. Most often cites general requirements (21 CFR 211.160).
- 1
- Documents on file
- 6.0
- Observations per 483
- 2020
- First seen
- 2020
- Most recent
What they cite most
From 6 observations- 21 CFR 211.160General requirements2
- 21 CFR 211.192Production record review2
- 21 CFR 211.111Time limitations on production1
- 21 CFR 211.25Personnel qualifications1
- 21 CFR 211.67Equipment cleaning and maintenance1
Activity by year
2020: 1
Where
New Hampshire 1
Often inspects with
Is Arulvathani Arudchandran coming to your site?
Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.
Ask about any investigator in Claude or ChatGPT with the AI connector.
Inspection history
1 document, newest first| Date | Firm | Location | Observations | Open |
|---|---|---|---|---|
| 2020-02-14 | 483 Novo Nordisk US Bio Production Inc.Feb 14, 2020 · West Lebanon, New Hampshire | West Lebanon, New Hampshire | 6 |
About this profile
What does Arulvathani Arudchandran inspect?
Arulvathani Arudchandran appears on 1 document on file covering 1 site, mostly in New Hampshire.
What do they cite most often?
21 CFR 211.160 (general requirements), followed by 21 CFR 211.192 and 21 CFR 211.111.
Can I read the observations?
Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.
How current is this profile?
The most recent document on file for Arulvathani Arudchandran is dated Feb 14, 2020.